Skip to main content

‘Wake up’, Zachert tells German politicians

10th August 2023

Submitted by:

Andrew Warmington

“Politicians need to finally wake up,” said Lanxess board chariman Matthias Zachert. “In the current phase of economic weakness, the location Germany is not competitive internationally. We urgently need sustainable framework conditions – above all an internationally competitive electricity tariff for the industry, the reduction of excessive bureaucracy and faster approval procedures.”

Zachert was speaking during the company’s Q2 results presentation, during which it also announced the ‘Forward!’ plan to counteract the current phase of weak economic development. The plan seeks to stabilise earnings in the short term, lower costs in the long term and refine structures and processes.

In the first stage, Lanxess has imposed a Europe-wide hiring freeze and reduced investments. This will lead to one-time savings of €100 million, half of which from cost reductions and half from lower investments.

In the longer term the company will seek to reduce costs by €150 million/year from 2025, with the focus on energy-intensive operations. The hexane oxidation facility at Krefeld-Uerdingen site will be shut down by 2026, while the chromium oxide facility will be sold if possible, or failing that, shut down as well. In the third phase, Lanxess will continue to reorient its portfolio toward speciality chemicals and further expand its range of sustainable products.

“The chemical industry and Lanxess are in a difficult situation right now,” Zachert said. There is currently no sign of a recovery in demand anticipated for the second half of the year. When the economy picks up again, we want to get back on track quickly” Zachert said. However this alone will not be enough and more government action is needed.

Q2 sales were 11.1% down year-on-year to €1778 million, due mainly to weak demand in many customer industries, ongoing inventory reduction among customers, and lower selling prices. EBITDA before exceptionals decreased by 57.7% to €107 million. Only the Consumer Protection segment achieved growth in sales.

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Axplora's site at Vizag

Axplora expands in India

Axplora has announced a “significant” investment at its site in Vizag, India (pictured)

Submitted by:

Andrew Warmington

Regis' headquarters in Chicago

Esteve acquires Regis

 

Barcelona-based Esteve Química has acquired Regis Technologies, a hitherto privately owned CDMO headquartered in Chicago

Submitted by:

Andrew Warmington

Meribel's facility at Uppsala

Ofichem buys site in Sweden

Netherlands-based CDMO Ofichem has acquired Meribel Pharma Solutions’ former Recipharm site in Uppsala, Sweden, which

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington